4-ipomeanol has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breakefield, XO; Chiocca, EA; Dobberstein, KU; Herrlinger, U; Hilton, J; Kramm, CM; Philpot, RM; Rainov, NG; Sena-Esteves, M | 1 |
| Breakefield, XO; Chiocca, EA; Dobberstein, KU; Fraefel, C; Rainov, NG; Sena-Esteves, M | 1 |
2 other study(ies) available for 4-ipomeanol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Brain Neoplasms; Culture Media, Conditioned; Cytochrome P-450 Enzyme System; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Genetic Therapy; Glioblastoma; Gliosarcoma; Glutathione; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Plasmids; Prodrugs; Rabbits; Rats; Terpenes; Transfection; Tumor Cells, Cultured | 1998 |
A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Base Sequence; Cell Division; Cell Survival; Cytochrome P-450 Enzyme System; DNA Fragmentation; DNA, Complementary; Genetic Therapy; Glioblastoma; Gliosarcoma; Green Fluorescent Proteins; Humans; Luminescent Proteins; Molecular Sequence Data; Prodrugs; Rats; Recombinant Fusion Proteins; Restriction Mapping; Terpenes; Tumor Cells, Cultured | 1998 |